Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
Clinical trial NCT04195139 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04195139
- Sponsor
- University of Sydney
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-22
- Primary completion
- 2024-06-28
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.